Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer.

Hiroki ShimizuYoshiaki KuriuTomohiro AritaJun KiuchiYusuke YamamotoHirotaka KonishiRyo MorimuraAtsushi ShiozakiHisashi IkomaTakeshi KubotaHitoshi FujiwaraKazuma OkamotoEigo Otsuji

Published in: World journal of surgery (2021)

T4N0 colon cancer had similar oncological characteristics and survival outcomes to T3N1 colon cancer. Systematic adjuvant chemotherapy, including oxaliplatin, should be incorporated into the therapy for T4N0 patients as well as T3N1 patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prostate cancer
prognostic factors